Related Experiment Video
Updated: Sep 25, 2026

Porcine Cardiac Arrest Model Using an Implantable Defibrillator
Published on: January 9, 2026
Eligibility for biventricular pacing in patients with an implantable cardioverter defibrillator
S G Molhoek1, J J Bax, L van Erven
1Dept of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.
Insights
Many patients receiving an implantable cardioverter defibrillator (ICD) also qualify for biventricular (BV) pacing. Combining ICD and BV pacing improves survival and reduces hospitalizations in heart failure patients.
Area of Science:
- Cardiology
- Medical Devices
- Heart Failure Management
Background:
- Implantable cardioverter defibrillator (ICD) therapy reduces sudden cardiac death but not heart failure mortality.
- Biventricular (BV) pacing shows promise for improving outcomes in heart failure patients.
Purpose of the Study:
- To determine the proportion of patients indicated for ICD implantation who are also eligible for BV pacing.
- To evaluate the combined benefits of ICD and BV pacing compared to ICD alone.
Main Methods:
- Retrospective analysis of 390 patients who received an ICD between June 1996 and March 2001.
- Eligibility for BV pacing assessed using NYHA class III-IV, QRS duration >120 ms, and depressed left ventricular ejection fraction (LVEF).
Main Results:
- Of 390 patients, 79 (20%) met criteria for BV pacing eligibility.
- Patients receiving both ICD and BV pacing demonstrated superior survival rates.
- Combined therapy led to improved NYHA class and significantly lower hospitalization rates compared to ICD alone.
Conclusions:
- A significant percentage of patients receiving ICDs are also candidates for BV pacing.
- Concurrent ICD and BV pacing offers substantial benefits for heart failure patients.
- Screening for BV pacing eligibility should be considered for patients undergoing ICD implantation.
Abstract:
Implantable cardioverter defibrillator (ICD)-therapy prevents sudden death in patients at high risk, but incidence of death due to heart failure remains unaltered. Recent data suggest that biventricular (BV) pacing is useful in patients with heart failure. It is unclear, how many patients with an ICD indication may have an indication for BV pacing. Therefore all patients who received an ICD were analyzed for eligibility of BV pacing using the following criteria: NYHA class III or IV, QRS duration >120 ms, depressed LVEF. Three hundred and ninety consecutive patients received an ICD from June 1996 to March 2001. Underlying disease was ischemic heart disease in 66%. In the 390 patients the mean LVEF was 36+/-17%, 20% were in NYHA class III-IV and 16% were in NYHA class II with an LVEF <30%. Of these 140 patients, 79 had a QRS duration >120 ms. Thus, 79 (20%) patients were eligible for BV pacing in addition to ICD-therapy. Patients who received a BV pacemaker in addition to ICD-therapy had a superior survival, improved in NYHA class and showed a significantly lower hospitalization rate as compared to patients who received an ICD only. Screening for eligibility of BV pacing may be considered in patients with CHF scheduled for ICD implantation.
More Related Videos
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Cardiopulmonary Resuscitation III: AED Use
Heart Failure IV: Classification and Diagnostic Evaluation
Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmias IV: Characteristics of Bradyarrhythmias

